1Dellinger RP,Carlet JM,Masur H,et al.Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J].Intensive Care Med,2004,30(4):536-555.
2Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Engl J Med,2001,345(19):1368-1377.
3De Backer D,Creteur J,Silva E,et al.Effects of dopamine,norepinephrine,and epinephrine on the splanchnic circulation in septic shock:which is best[J]? Crit Care Med,2003,31(6):1659-1667.
4Kellum JA,M Decker J.Use of dopamine in acute renal failure:a meta-analysis[J].Crit Care Med,2001,29(8):1526-1531.
5Annane D,Sebille V,Charpentier C,et al.Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock[J].JAMA,2002,288(7):862-871.
6van den Berghe G,Wouters P J,Bouillon R,et al.Outcome benefit of intensive insulin therapy in the critically ill:Insulin dose versus glycemic control[J].Crit Care Med,2003,31 (2):359-366.
7Bernard GR,Vincent JL,Laterre PF,et al.Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group.Efficacy and safety of recombinant human activated protein C for severe sepsis[J].N Engl J Med,2001(10),344:699-709.
10Rivers E,Nguyen B,Havstad S,et al.Early goaldirected therapy in the treatment of severe sepsis and septic shock[J].N Engl J Med,2001,345(19):1368-1377.
